Researchers from Eindhoven University of Technology (TU/e) and Keio University today present a practicable and reliable way to test for infectious diseases.
All you need are a special glowing paper strip, a drop of blood and a digital camera, as they write in the scientific journal Angewandte Chemie. Not only does this make the technology very cheap and fast – after twenty minutes it is clear whether there is an infection – it also makes expensive and time-consuming laboratory measurements in the hospital unnecessary. In addition, the test has a lot of potential in developing countries for the easy testing of tropical diseases.
The test shows the presence of infectious diseases by searching for certain antibodies in the blood that your body makes in response to, for example, viruses and bacteria. The development of handy tests for the detection of antibodies is in the spotlight as a practicable and quick alternative to expensive, time-consuming laboratory measurements in hospitals. Doctors are also increasingly using antibodies as medicines, for example in the case of cancer or rheumatism. So this simple test is also suitable for regularly monitoring the dose of such medicines to be able to take corrective measures in good time.
The use of the paper strip developed by the Dutch and Japanese researchers is a piece of cake. Apply a drop of blood to the appropriate place on the paper, wait twenty minutes and turn it over. “A biochemical reaction causes the underside of paper to emit blue-green light,” says Eindhoven University of Technology professor and research leader Maarten Merkx. “The bluer the color, the higher the concentration of antibodies.” A digital camera, for example from a mobile phone, is sufficient to determine the exact color and thus the result.
The color is created thanks to the secret ingredient of the paper strip: a so-called luminous sensor protein developed at TU/e. After a droplet of blood comes onto the paper, this protein triggers a reaction in which blue light is produced (known as bioluminescence). An enzyme that also illuminates fireflies and certain fish, for example, plays a role in this. In a second step, the blue light is converted into green light. But here comes the clue: if an antibody binds to the sensor protein, it blocks the second step. A lot of green means few antibodies and, vice versa, less green means more antibodies.
The ratio of blue and green light can be used to derive the concentration of antibodies. “So not only do you know whether the antibody is in the blood, but also how much,” says Merkx. By measuring the ratio precisely, they suffer less from problems that other biosensors often have, such as the signal becoming weaker over time. In their prototype, they successfully tested three antibodies simultaneously, for HIV, flu and dengue fever. Merkx expects the test to be commercially available within a few years.
The Latest on: Test for infectious diseases
via Google News
The Latest on: Test for infectious diseases
- Pfizer-BioNTech will begin testing booster shot to combat variants; Alaska Gov. Mike Dunleavy tests positive. Live COVID-19 updates.on February 25, 2021 at 5:27 am
The Biden administration plans to distribute more than 25 million masks to community health centers. U.S. deaths top 505K. Latest COVID-19 updates.
- VCU infectious disease expert says US could achieve herd immunity by summeron February 25, 2021 at 12:37 am
VCU researchers say falling COVID-19 cases being observed nationwide suggests that herd immunity could come sooner than expected.
- Moderna Ships a New COVID-19 Vaccine for Testing Against More Infectious Varianton February 24, 2021 at 5:43 pm
Massachusetts-based biotech Moderna announced that has shipped a new version of its already-authorized COVID-19 vaccine to testing sites. The new vaccine is one aspect of a three-part strategy the ...
- Moderna to test booster shot targeting South African varianton February 24, 2021 at 3:09 pm
Vaccine developer Moderna said Wednesday it has manufactured a booster of its coronavirus vaccine that is specifically targeted to stop a variant of the disease first found in South Africa.
- Minnesota health officials recommend more COVID-19 tests for familieson February 24, 2021 at 1:59 pm
Federal health authorities on Wednesday said a vaccine developed by Johnson & Johnson that requires only one dose is safe and effective. It was unclear when the vaccine will be available in Minnesota, ...
- FDA: New Variants Mean COVID-19 Vaccines, Tests May Need Tweakingon February 24, 2021 at 4:43 am
The U.S. Food and Drug Administration issued guidelines Monday encouraging drug and test developers to pay attention to new coronavirus variants and be prepared to make that pivot if necessary. The ...
- They’re harnessing the power of Big Data to track COVID-19 and other diseaseson February 23, 2021 at 4:00 pm
In partnership with Google.org and The Rockefeller Foundation, a team of researchers led by Northeastern professor Samuel Scarpino has launched Global.health, a collaborative platform that ...
- Data Analytics Model Gages False-Negative Rate for COVID-19 Testson February 23, 2021 at 10:00 am
A data analytics tool can assess the false-negative rate of COVID-19 tests, potentially reducing the spread of the virus.
- Global Infectious Diseases Diagnostics Market to Witness Splendid Growth by 2024 - Trends, Demand and Detailed Analysison February 19, 2021 at 9:49 pm
The global infectious diseases diagnostics market reached US$24.32 billion in 2024, growing at a CAGR of 3.30% for ...
via Bing News